Where are we with mRNA neoantigen vaccinations? / Ryan Sullivan.

Format:

Video

Author/Creator:

Sullivan, Ryan, author.

Language:

English

Subjects (All):

Tumors--therapy.

Tumors.

Vaccination.

Physical Description:

1 streaming video file (27 min., 41 sec.) : color, sound

Place of Publication:

London : Henry Stewart Talks Ltd, 2025.

System Details:

video file

Contents:

Introduction

Vaccines in cancer: the basics (1)

Vaccines in cancer: the basics (2)

Vaccines in cancer: the basics (3)

Vaccines in cancer: the numbers

Vaccines in melanoma: the numbers

Vaccines in cancer: decades of failure (1)

Vaccines in cancer: decades of failure (2)

Vaccines in melanoma: decades of failure (1)

Vaccines in melanoma: decades of failure (2)

Vaccines: the road ahead

Neoantigen vaccination

Initial efforts at peptide-based neoantigen tumor vaccine

A phase Ib trial of personalized neoantigen therapy plus anti-PD-1

A phase lb study to evaluate RO7198457

IMCODE-011/GO40559 (NCT03815058)

mRNA-4157 vaccine

Adjuvant, stage III melanoma cohort

Neoantigen vaccination: proof of principle (1)

Neoantigen vaccination: proof of principle (2)

Neoantigen vaccination: proof of principle (3)

Neoantigen vaccination: safety

Neoantigen vaccination: subset analysis (1)

Neoantigen vaccination: subset analysis (2)

Neoantigen vaccination: subset analysis (3)

Tumor vaccination in 2024.

Notes:

Description based on publisher supplied metadata and other sources.

Retrieved August 14, 2025, from https://doi.org/10.69645/WMUV4275.